Paramita Chakraborty to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Paramita Chakraborty has written about Drug Resistance, Neoplasm.
Connection Strength
0.350
-
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer. Eur J Pharm Sci. 2014 Jan 23; 51:96-109.
Score: 0.094
-
Targeting the mitochondrial pathway to induce apoptosis/necrosis through ROS by a newly developed Schiff's base to overcome MDR in cancer. Biochimie. 2012 Jan; 94(1):166-83.
Score: 0.082
-
Iron N-(2-hydroxy acetophenone) glycinate (FeNG), a non-toxic glutathione depletor circumvents doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo. Biometals. 2012 Feb; 25(1):149-63.
Score: 0.081
-
Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate. PLoS One. 2010 Jun 22; 5(6):e11253.
Score: 0.075
-
A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells. PLoS One. 2009 Sep 16; 4(9):e7048.
Score: 0.018